Pancreatic Cancer Research

ResearcherNingbo UniversityNo recent work listed

Qiang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5129-2603; OpenAlex author ID A5100429872. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
54
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 3 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 4 papers · 2023: 3 papers

Papers 16

  1. The SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer. Co-author DOI 10.1155/2023/6891636↗
  2. Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer. Last author DOI 10.1186/s12885-023-10908-0↗
  3. Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and in vitro experiments. Co-author DOI 10.3389/fimmu.2023.1242909↗
  4. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Co-author DOI 10.1001/jamanetworkopen.2021.48721↗
  5. Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer. Co-author DOI 10.1002/ijc.33877↗
  6. Radiofrequency Hyperthermia Enhances Locally Delivered Oncolytic Immuno-Virotherapy for Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s00270-022-03210-2↗
  7. Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer. Co-author DOI 10.3389/fgene.2022.990661↗
  8. CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.832315↗
  9. Nutrient Stress-Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-18-0419↗
  10. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Co-author DOI 10.1038/s41388-018-0382-1↗
  11. Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis. Co-author DOI 10.1111/cpr.12428↗
  12. Top classic citations in pancreatic cancer research. Co-author DOI 10.1186/s12957-016-1061-8↗
  13. MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2. Co-author DOI 10.1016/j.canlet.2012.11.005↗
  14. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin. Co-author DOI 10.1016/j.pan.2013.05.008↗
  15. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. First author DOI 10.3892/ijo.2013.2015↗
  16. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an i… Co-author DOI 10.1097/mpa.0b013e318217945e↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yunpeng Peng · 5 shared papers, 2018–2023 · strength 0.72
  2. Kuirong Jiang · 6 shared papers, 2011–2023 · strength 0.64
  3. Xiaole Zhu · 3 shared papers, 2018–2023 · strength 0.44
  4. Zipeng Lu · 4 shared papers, 2011–2023 · strength 0.43
  5. Min Tu · 4 shared papers, 2013–2022 · strength 0.34
  6. Yi Miao · 4 shared papers, 2011–2022 · strength 0.34
  7. Wentao Gao · 5 shared papers, 2011–2022 · strength 0.32
  8. Jishu Wei · 5 shared papers, 2011–2022 · strength 0.32
  9. Junli Wu · 5 shared papers, 2011–2022 · strength 0.32
  10. Lingdi Yin · 3 shared papers, 2018–2022 · strength 0.31
  11. Kai Zhang · 2 shared papers, 2021–2022 · strength 0.23
  12. Chunhua Xi · 2 shared papers, 2021–2022 · strength 0.23
  13. Feng Zhang · 1 shared paper, 2022 · strength 0.20
  14. Xiaoming Yang · 1 shared paper, 2022 · strength 0.20
  15. Wei Xu · 1 shared paper, 2023 · strength 0.19
  16. Qi Wang · 1 shared paper, 2023 · strength 0.19
  17. Chunfang Xu · 1 shared paper, 2023 · strength 0.19
  18. Wenjia Zhang · 1 shared paper, 2023 · strength 0.19
  19. Shouji Cao · 1 shared paper, 2023 · strength 0.18
  20. Wanli Ge · 1 shared paper, 2023 · strength 0.18
  21. Lingdong Meng · 1 shared paper, 2023 · strength 0.18
  22. Miao Yi · 1 shared paper, 2023 · strength 0.17
  23. Kai Zhang · 1 shared paper, 2023 · strength 0.17
  24. Feng Guo · 1 shared paper, 2023 · strength 0.17
  25. Shi-Jiang Deng · 2 shared papers, 2018–2019 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.